InSite Vision, Inc.
InSite Vision, Inc.
Global collaborations in ophthalmic therapy are
setting the stage for expansion

InSite Vision, a SUN PHARMA company develops novel ophthalmic products designed to treat a growing range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Our goal is to provide patients and physicians with improved treatment options that help preserve and improve vision worldwide.

Sun Pharma receives US FDA approval for BromSite. The first NSAID approved for prevention of ocular pain in patients undergoing cataract surgery.